NASDAQ: VNDA
Vanda Pharmaceuticals Inc Earnings Dates, Reports, Calls

Vanda Pharmaceuticals earnings were -$18.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest VNDA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$4.9M, down 7.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VNDA reported annual earnings of -$18.9M, with -853.3% growth. The next VNDA earnings date is May 6, 2025.

VNDA earnings history

Current Revenue
$198.8M
Current Earnings
-$18.9M
Current Profit Margin
-9.5%

VNDA Return on Equity

Current Company
-3.5%
Current Industry
-1.4%
Current Market
34.2%
VNDA's Return on Equity (-3.5%)... subscribe to Premium to read more.
High Return on Equity Performance

VNDA undefined

Current Company
-2.9%
Current Industry
0.2%
VNDA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VNDA announces earnings.

VNDA undefined

Current Company
-4.12%
Current Industry
6.6%
VNDA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VNDA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VNDA-$14.79M-$18.90MN/A-$0.33
PROK-$56.34M-$61.19MN/A-$0.62
CMPX-$47.62M-$49.38MN/A-$0.36
OLMA-$127.93M-$129.47MN/A-$2.20
SEPNN/AN/AN/AN/A

VNDA earnings dates

Next earnings date
May 6, 2025

Vanda Pharmaceuticals Earnings Reports & History FAQ

What were Vanda Pharmaceuticals's earnings last quarter?

On VNDA's earnings call on Invalid Date, Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 2024 earnings per share (EPS) of -$0.09, up 80% year over year. Total VNDA earnings for the quarter were -$4.91 million. In the same quarter last year, Vanda Pharmaceuticals's earnings per share (EPS) was -$0.05.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.

When does Vanda Pharmaceuticals report earnings?

The next VNDA earnings call is Invalid Date. Add VNDA to your watchlist to be reminded of Vanda Pharmaceuticals's next earnings date.

Is Vanda Pharmaceuticals profitable or losing money?

As of the last Vanda Pharmaceuticals earnings report, Vanda Pharmaceuticals is currently losing money. Vanda Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$18.90 million, a 853.29% decrease year over year.

What was VNDA's earnings growth in the past year?

As of Vanda Pharmaceuticals's earnings date in Invalid Date, Vanda Pharmaceuticals's earnings has grown year over year. VNDA earnings in the past year totalled -$18.90 million.

What are Vanda Pharmaceuticals's earnings expectations?

The current EPS estimate for Vanda Pharmaceuticals's earnings report in Invalid Date is $0.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.